Achieve Life Sciences
ACHV
47 hedge funds and large institutions have $7.07M invested in Achieve Life Sciences in 2015 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 9 closing their positions.
33% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 9
4% more funds holding
Funds holding: 45 → 47 (+2)
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
51% less capital invested
Capital invested by funds: $14.4M → $7.07M (-$7.37M)
96% less call options, than puts
Call options by funds: $3K | Put options by funds: $73K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ARTA
A.R.T. Advisors
New York
|
+$211K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$182K |
| 3 |
EGA
Eagle Global Advisors
Houston,
Texas
|
+$178K |
| 4 |
Renaissance Technologies
New York
|
+$76.1K |
| 5 |
LPL Financial
San Diego,
California
|
+$67.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$669K |
| 2 |
A
Abingworth
London,
United Kingdom
|
-$397K |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$334K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$168K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$165K |
ACHV Hedge Fund Activity: Q4 2015 in Review
47 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q4 2015, worth a combined $7.07M — down 51% from $14.4M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ACHV positions and 9 closed out — a net gain of 3 holders — while 10 added to existing stakes and 12 trimmed.
The largest buyer was A.R.T. Advisors, opening a new position worth an estimated $211K. The largest seller was Wexford Capital, exiting entirely with an estimated $669K sold.
- 47 institutional investors held Achieve Life Sciences (ACHV) as of Q4 2015, up from 45 in Q3 2015.
- Funds reported $7.07M of Achieve Life Sciences stock for Q4 2015, down 51% quarter-over-quarter.
- 12 funds opened new Achieve Life Sciences positions in Q4 2015 and 9 closed out, a net change of +3 holders.
- The largest Achieve Life Sciences buyer in Q4 2015 was A.R.T. Advisors, an estimated $211K added.
- The largest Achieve Life Sciences seller in Q4 2015 was Wexford Capital, an estimated $669K sold.
Based on aggregated 13F filings for Q4 2015.